Navigation Links
Indevr launches breakthrough colorimetric detection for microarrays using core technology from CU
Date:11/17/2011

BOULDER, Colo. November 2011 InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary new technology for microbiological analysis. ampliPHOX, a colorimetric detection system that incorporates core technology licensed from the University of Colorado Technology Transfer Office, will enhance laboratories around the world by offering a cost effective and easy to use alternative to fluorescence detection.

ampliPHOX instrumentation costs less than one-tenth the price of typical fluorescence microarray readers. The ampliPHOX process relies on an innovative photopolymerization approach. Colorimetric readouts with equivalent sensitivity to fluorescence are delivered within minutes and results are visible to the naked eye. ampliPHOX works with any biotinylated target captured on a glass surface. The Journal of Visualized Experiments (JoVE), a peer reviewed scientific video journal, recently featured ampliPHOX for its powerful pathogen detection abilities.

"ampliPHOX offers an incredible opportunity for a wide range of laboratories at a fraction of the cost," Kathy Rowlen, PhD, CEO and co-founder of InDevR, said. "With this technology, scientists can unleash the tremendous potential of low density microarrays for a myriad of applications; everything from pathogen detection with nucleic acids to disease state profiling with proteins."

In addition to saving money for lab analyses, the small reader and laptop will also save space, said Rowlen. ampliPHOX weighs just 3 pounds, is intended for easy transport and convenient storage in a lab and requires little on-site training.

"ampliPHOX is a product that will change the way technology works in labs around the world," said David Allen, PhD, associate vice president for technology transfer at CU. "CU technology contributed to this innovative product that will save money and time for countless scientists, which is especially helpful in our current economy."

Rowlen added that ampliPHOX is a success story for small business in America. "The intellectual property was licensed by InDevR from the University of Colorado; research and development was funded by the National Institute of Allergy and Infectious Disease; and I am especially pleased that the State of Colorado believed enough in InDevR to provide a small, but extremely helpful commercialization grant through the forward thinking BioScience Discovery Grant program. The result is a new technology on the market and new jobs in Colorado."

To make the ampliPHOX system even more affordable, InDevR currently offers free ampliPHOX instruments to customers who purchase 10 reagent kits. The limited-time offer is available on its website, http://www.indevr.com.


'/>"/>
Contact: Rhonda Spencer
spencer@indevr.com
303-402-9100
University of Colorado at Boulder
Source:Eurekalert

Related medicine news :

1. InDevR awarded $3 million grant from NIH for influenza-related research
2. State Sen. Jeff Klein launches Einsteins new lab
3. IPAL-EM launches to improve palliative care in emergency medicine
4. Harvard Medical School launches major initiative to address crisis in drug development
5. TGen-Virginia G. Piper Cancer Center launches clinical trial for drug to treat lung cancer
6. Autism Speaks launches blood draw tool kit -- practical guidance for parents and providers
7. UT Southwestern launches hand transplant program
8. 23andMe launches myeloproliferative neoplasms research initiative
9. International conference launches revolutionary South Asia autism network
10. DNDi launches new drug development program to address treatment needs of children with HIV/AIDS
11. UNH launches joint Sustainable Agro-Ecosystems Lab with Chinese Academy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The physicians of KSF ... the greater Houston Area. The new location is located at 2255 E. Mossy Oaks ... Springwoods Village. This newest location will provide patients living in the north Houston area ...
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) ... Road in Building 2. The clinic is the group’s second in New Braunfels and ... the company’s second New Braunfels location brings things full circle for the group, “It’s ...
(Date:3/23/2017)... ... , ... The IoT (Internet of Things) is revolutionizing the way the world ... businesses and individual consumers alike. Laboratories can maximize their profit margin by increasing ... $4 trillion to $11 trillion dollars by the year 2025. McKinsey expects the IoT ...
(Date:3/23/2017)... , ... March 23, 2017 , ... 82% of adults are unaware of the dangers ... not brush their teeth the minimum two times a day that dentists recommend. The ramifications ... 51 million hours of school and adults missing 164 million hours of work each year ...
(Date:3/23/2017)... ... ... March is National Kidney Month – the perfect time to pause and thank ... Every day, two kidneys filter about 120 to 150 quarts of blood. Put another ... regulating fluid levels and blood pressure, supporting bone health and promoting red blood cell ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017 FinancialBuzz.com News Commentary  ... According to new ... market research, the legal cannabis market is projected to continue ... conflicting signals from the current presidential administration. The report created ... biggest drivers of growth in this industry are the passage ...
(Date:3/24/2017)... 24, 2017 Research and Markets has announced the ... report to their offering. ... The IPF pipeline is very strong with a total of 97 ... Inc., Biogen and Sanofi are involved in the development of the IPF ... is in Phase III stage, 15 are in Phase II stage, 12 ...
(Date:3/24/2017)... , March 24, 2017 A ReportsnReports.com ... has been growing rapidly as the global sales of Adcetris and ... growth in the antibody drug conjugates market is driven by large ... cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, ...
Breaking Medicine Technology: